Abstract

The effect of beta carotene on AMNU-induced carcinogenesis was studied in rats. Administration of beta carotene reliably decreased both the total incidence of tumors and the incidence of renal tumors. The results are an experimental validation of the possibility of using beta carotene to lower the risk of second primary malignancies during the treatment of cancer patients with nitrosoalkylurea drugs.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call